These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17043651

  • 21. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 22. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P.
    Clin Cancer Res; 1999 Apr 04; 5(4):845-54. PubMed ID: 10213221
    [Abstract] [Full Text] [Related]

  • 23. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
    Kiprianova I, Remy J, Milosch N, Mohrenz IV, Seifert V, Aigner A, Kögel D.
    Neoplasia; 2015 Jul 04; 17(7):564-73. PubMed ID: 26297434
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 25. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
    Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):29-39. PubMed ID: 17395690
    [Abstract] [Full Text] [Related]

  • 26. Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells.
    Kim HG, Hwang YP, Jeong HG.
    Toxicol Lett; 2009 May 22; 187(1):28-34. PubMed ID: 19429240
    [Abstract] [Full Text] [Related]

  • 27. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC, Ball S, Lin L, Liu A, Fuchs JR, Li PK, Li C, Lin J.
    Int J Oncol; 2011 Jan 22; 38(1):279-85. PubMed ID: 21109950
    [Abstract] [Full Text] [Related]

  • 28. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y.
    Life Sci; 2007 Sep 29; 81(16):1256-63. PubMed ID: 17919663
    [Abstract] [Full Text] [Related]

  • 29. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
    Zhou X, Ren Y, Liu A, Han L, Zhang K, Li S, Li P, Li P, Kang C, Wang X, Zhang L.
    Oncol Rep; 2014 May 29; 31(5):2173-80. PubMed ID: 24676554
    [Abstract] [Full Text] [Related]

  • 30. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):738-44. PubMed ID: 17904524
    [Abstract] [Full Text] [Related]

  • 31. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ, Shen L, Wang ZY, Hui SY, Huang YG, Ma C.
    Brain Res; 2014 Oct 02; 1583():79-88. PubMed ID: 25084036
    [Abstract] [Full Text] [Related]

  • 32. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Tsujita Y, Horiguchi A, Tasaki S, Isono M, Asano T, Ito K, Asano T, Mayumi Y, Kushibiki T.
    Oncol Rep; 2017 Oct 02; 38(4):2197-2204. PubMed ID: 28849140
    [Abstract] [Full Text] [Related]

  • 33. Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma.
    Tsutsui M, Yasuda H, Suto H, Imai H, Isobe Y, Sasaki M, Kojima Y, Oshimi K, Sugimoto K.
    Int J Lab Hematol; 2010 Aug 01; 32(4):419-26. PubMed ID: 19968719
    [Abstract] [Full Text] [Related]

  • 34. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 01; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
    Shen J, Li R, Li G.
    In Vivo; 2009 Jul 01; 23(2):237-43. PubMed ID: 19414409
    [Abstract] [Full Text] [Related]

  • 36. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
    Zhang L, Alizadeh D, Van Handel M, Kortylewski M, Yu H, Badie B.
    Glia; 2009 Oct 01; 57(13):1458-67. PubMed ID: 19306372
    [Abstract] [Full Text] [Related]

  • 37. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L, Arulampalam V, Hjortsberg L, Farnebo M, Grandér D, Pokrovskaja Tamm K.
    Exp Cell Res; 2007 Nov 15; 313(19):4015-24. PubMed ID: 17880940
    [Abstract] [Full Text] [Related]

  • 38. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M.
    Oncol Rep; 2008 Apr 15; 19(4):1061-6. PubMed ID: 18357397
    [Abstract] [Full Text] [Related]

  • 39. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
    Assi HH, Paran C, VanderVeen N, Savakus J, Doherty R, Petruzzella E, Hoeschele JD, Appelman H, Raptis L, Mikkelsen T, Lowenstein PR, Castro MG.
    J Pharmacol Exp Ther; 2014 Jun 15; 349(3):458-69. PubMed ID: 24696041
    [Abstract] [Full Text] [Related]

  • 40. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
    Swiatek-Machado K, Mieczkowski J, Ellert-Miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska B.
    Cancer Biol Ther; 2012 Jun 15; 13(8):657-70. PubMed ID: 22555804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.